ARTICLE | Product Development
Apex takes on the shock in sepsis
March 24, 1997 8:00 AM UTC
A hemoglobin derivative is the latest biotech foray toward the industry black hole of sepsis. But Joseph DeAngelo, the co-inventor of the technology, emphasizes that the treatment is for shock
A hemoglobin derivative is the latest biotech foray toward the industry black hole of sepsis. But Joseph DeAngelo, the co-inventor of the technology, emphasizes that the treatment is for shock...